GSK unit wins partial dismissal in dostarlimab licence dispute with AnaptysBio

GSK PLC's (LSE:GSK, NYSE:GSK) oncology subsidiary TESARO has secured a partial legal victory after a Delaware court dismissed a counterclaim brought by...